ZSAN Annual CFF
$8.79 M
-$60.36 M-87.28%
31 December 2021
Summary:
As of February 5, 2025, ZSAN annual cash flow from financing activities is $8.79 million, with the most recent change of -$60.36 million (-87.28%) on December 31, 2021. During the last 3 years, it has fallen by -$37.03 million (-80.81%).ZSAN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZSAN Quarterly CFF
$11.09 M
+$10.96 M+8115.56%
31 March 2022
Summary:
As of February 5, 2025, ZSAN quarterly cash flow from financing activities is $11.09 million, with the most recent change of +$10.96 million (+8115.56%) on March 31, 2022. Over the past year, it has increased by +$8.78 million (+379.09%).ZSAN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZSAN TTM CFF
$17.57 M
+$8.78 M+99.81%
31 March 2022
Summary:
As of February 5, 2025, ZSAN TTM cash flow from financing activities is $17.57 million, with the most recent change of +$8.78 million (+99.81%) on March 31, 2022. Over the past year, it has dropped by -$31.83 million (-64.43%).ZSAN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZSAN Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -87.3% | +379.1% | -64.4% |
| 3 y3 years | -80.8% | +2262.0% | -41.1% |
| 5 y5 years | -64.8% | -62.3% | -41.1% |
ZSAN Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -87.3% | -81.6% | -77.6% |
Zosano Pharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $11.09 M(+8115.6%) | $17.57 M(+99.8%) |
| Dec 2021 | $8.79 M(-87.3%) | $135.00 K(-93.2%) | $8.79 M(+18.4%) |
| Sept 2021 | - | $2.00 M(-54.1%) | $7.42 M(-85.3%) |
| June 2021 | - | $4.35 M(+87.8%) | $50.43 M(+2.1%) |
| Mar 2021 | - | $2.31 M(-287.8%) | $49.40 M(-28.6%) |
| Dec 2020 | $69.15 M(+131.8%) | -$1.23 M(-102.7%) | $69.15 M(-11.9%) |
| Sept 2020 | - | $45.00 M(+1258.8%) | $78.50 M(+119.9%) |
| June 2020 | - | $3.31 M(-85.0%) | $35.70 M(-31.9%) |
| Mar 2020 | - | $22.07 M(+172.1%) | $52.41 M(+75.7%) |
| Dec 2019 | $29.83 M(-34.9%) | $8.11 M(+268.4%) | $29.83 M(+27.8%) |
| Sept 2019 | - | $2.20 M(-89.0%) | $23.33 M(+2.3%) |
| June 2019 | - | $20.03 M(-4004.1%) | $22.82 M(-51.3%) |
| Mar 2019 | - | -$513.00 K(-131.7%) | $46.84 M(+2.2%) |
| Dec 2018 | $45.82 M(+83.3%) | $1.62 M(-4.3%) | $45.82 M(+7.3%) |
| Sept 2018 | - | $1.69 M(-96.2%) | $42.71 M(+8.0%) |
| June 2018 | - | $44.05 M(-2984.5%) | $39.56 M(-767.9%) |
| Mar 2018 | - | -$1.53 M(+2.1%) | -$5.92 M(-123.7%) |
| Dec 2017 | $25.00 M | -$1.50 M(+2.2%) | $25.00 M(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$1.46 M(+1.9%) | $24.98 M(-21.3%) |
| June 2017 | - | -$1.44 M(-104.9%) | $31.72 M(-4.3%) |
| Mar 2017 | - | $29.39 M(-2042.6%) | $33.16 M(+779.4%) |
| Dec 2016 | $3.77 M(-93.8%) | -$1.51 M(-128.7%) | $3.77 M(-28.6%) |
| Sept 2016 | - | $5.28 M(>+9900.0%) | $5.28 M(>+9900.0%) |
| June 2016 | - | $5000.00(+400.0%) | $2000.00(-99.4%) |
| Mar 2016 | - | $1000.00(>+9900.0%) | $337.00 K(-99.4%) |
| Dec 2015 | $60.53 M(+723.7%) | $0.00(-100.0%) | $60.53 M(-1.5%) |
| Sept 2015 | - | -$4000.00(-101.2%) | $61.46 M(-0.0%) |
| June 2015 | - | $340.00 K(-99.4%) | $61.47 M(-5.5%) |
| Mar 2015 | - | $60.20 M(+6393.7%) | $65.05 M(+785.1%) |
| Dec 2014 | $7.35 M(+108.5%) | $927.00 K(>+9900.0%) | $7.35 M(+14.4%) |
| Sept 2014 | - | $2000.00(-99.9%) | $6.42 M(+0.0%) |
| June 2014 | - | $3.92 M(+56.8%) | $6.42 M(+156.8%) |
| Mar 2014 | - | $2.50 M(>+9900.0%) | $2.50 M(>+9900.0%) |
| Dec 2013 | $3.52 M(-417.0%) | - | - |
| Mar 2013 | - | $0.00 | $0.00 |
| Dec 2012 | -$1.11 M | - | - |
FAQ
- What is Zosano Pharma annual cash flow from financing activities?
- What is the all time high annual CFF for Zosano Pharma?
- What is Zosano Pharma annual CFF year-on-year change?
- What is Zosano Pharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Zosano Pharma?
- What is Zosano Pharma quarterly CFF year-on-year change?
- What is Zosano Pharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for Zosano Pharma?
- What is Zosano Pharma TTM CFF year-on-year change?
What is Zosano Pharma annual cash flow from financing activities?
The current annual CFF of ZSAN is $8.79 M
What is the all time high annual CFF for Zosano Pharma?
Zosano Pharma all-time high annual cash flow from financing activities is $69.15 M
What is Zosano Pharma annual CFF year-on-year change?
Over the past year, ZSAN annual cash flow from financing activities has changed by -$60.36 M (-87.28%)
What is Zosano Pharma quarterly cash flow from financing activities?
The current quarterly CFF of ZSAN is $11.09 M
What is the all time high quarterly CFF for Zosano Pharma?
Zosano Pharma all-time high quarterly cash flow from financing activities is $60.20 M
What is Zosano Pharma quarterly CFF year-on-year change?
Over the past year, ZSAN quarterly cash flow from financing activities has changed by +$8.78 M (+379.09%)
What is Zosano Pharma TTM cash flow from financing activities?
The current TTM CFF of ZSAN is $17.57 M
What is the all time high TTM CFF for Zosano Pharma?
Zosano Pharma all-time high TTM cash flow from financing activities is $78.50 M
What is Zosano Pharma TTM CFF year-on-year change?
Over the past year, ZSAN TTM cash flow from financing activities has changed by -$31.83 M (-64.43%)